Revive Therapeutics Ltd (RVVTF)

[ellerk88]

When FDA verbiage is used to describe a drug, I expect that drug to have been through the formal process. I addressed the Phase 2 crossover allowance due to NAC efficacy on ACE inhibition in another comment.

Words matter, people. As excited as you can get about an equity, it's still disingenuous to spread misinformation. Revive has too many good things in place for some stretched information to attack validity. This group is too in tune for that PINK BS. Despite RVVTF still sitting on PINKs, We want them to be a big dog - hold yourselves to higher standards with your diligence.